Music therapy for cancer patients in palliative care
Meraki: Music Therapy Protocol for People with Palliative Care
This study is testing whether music therapy can help improve the emotional well-being and quality of life for cancer patients in palliative care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Valencia Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Serra, Valencia) |
| Trial ID | NCT06345924 on ClinicalTrials.gov |
What this trial studies
This study aims to analyze the impact of music therapy on the emotional well-being and quality of life of cancer patients receiving palliative care. It involves implementing an individualized music therapy treatment program designed to improve adaptation to illness and psychological well-being. The effectiveness and efficiency of this approach will be validated through assessments before and after treatment sessions. Participants will engage in multiple sessions to evaluate the therapy's impact on their overall experience during advanced stages of cancer.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old receiving palliative care for cancer, with preserved cognitive ability and not in the final days of life.
Not a fit: Patients with a life expectancy of two weeks or less may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance the emotional and psychological well-being of cancer patients in palliative care.
How similar studies have performed: Other studies have shown promising results with music therapy in improving quality of life for cancer patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is receiving palliative care for an oncological diagnosis and was admitted to the hospital a week ago. They do not have moderate to severe cognitive impairment. This treatment is for oncological patients in an advanced stage who are receiving palliative anti-tumour treatment such as chemotherapy and/or radiotherapy. These patients require support treatment that cannot be provided at home due to their complexity. The patient is in an advanced or terminal phase of the disease according to WHO criteria. * Be over 18 years of age. * Have preserved cognitive ability (SPMSQ, Pfeiffer). More than 2 errors (3 in illiterate persons) would suggest the presence of cognitive impairment. * Have signed the informed consent form * Have completed at least 2 of the 3 treatment sessions and have completed the pre-test and post-test assessment. Exclusion Criteria: -Estimated survival time. Patients with a life expectancy of two weeks or less shall not be operated on.
Where this trial is running
Serra, Valencia
- Hospital Dr. Moliner — Serra, Valencia, Spain (Recruiting)
Study contacts
- Principal investigator: Marián Pérez Marín, PhD — University of Valencia
- Study coordinator: Marián Pérez-Marín, PhD
- Email: marian.perez@uv.es
- Phone: 963983392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.